Skip to main content

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Liu's full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Coney Island Hospital
    Coney Island HospitalResidency, Internal Medicine, 2007 - 2010
  • The Second Military Medicine  Univ
    The Second Military Medicine UnivClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2023 - 2025
  • PA State Medical License
    PA State Medical License 2010 - 2024
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013

Publications & Presentations

PubMed

Abstracts/Posters

  • Targeting PI3K and PLK1 to Overcome Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma
    Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • BI-1206, a Monoclonal Antibody Against Fc_riib, Showed Superior Anti-Tumor Activity in an Ibrutinib-Venetoclax Dual Resistant PDX Model in Mantle Cell Lymphoma
    Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Clinical efficacy of tumor-treating fields for newly diagnosed glioblastoma. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
  • The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Maryland’s Institute of Human Virology Form New Theory to Improve Efficacy & Safety of Immunotherapy Drugs
    Maryland’s Institute of Human Virology Form New Theory to Improve Efficacy & Safety of Immunotherapy DrugsDecember 31st, 2019
  • Stand up to Cancer & Society for Immunotherapy of Cancer Award 5 Convergence Fellowships
    Stand up to Cancer & Society for Immunotherapy of Cancer Award 5 Convergence FellowshipsAugust 7th, 2019
  • Umosm Institute of Human Virology Scientists Propose New Theory for Cancer Immunotherapy
    Umosm Institute of Human Virology Scientists Propose New Theory for Cancer ImmunotherapyFebruary 22nd, 2019

Hospital Affiliations